Summary

Global Binge-eating Disorder Treatment Market 2023-2027
The binge-eating disorder treatment market is forecasted to grow by USD 578.04 mn during 2022-2027, accelerating at a CAGR of 7.26% during the forecast period. The report on the binge-eating disorder treatment market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of binge-eating disorder, the growing obese population, and rising government initiatives.
Technavio's binge-eating disorder treatment market is segmented as below:
By Distribution Channel
• Offline
• Online
By Type
• Antidepressants
• Anticonvulsants
• Stimulants and others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the development and approval of new drugs as one of the prime reasons driving the binge-eating disorder treatment market growth during the next few years. Also, increasing preference for partial hospitalization programs (PHP) and the emergence of virtual telemedicine will lead to sizable demand in the market.
The report on the binge-eating disorder treatment market covers the following areas:
• Binge-eating disorder treatment market sizing
• Binge-eating disorder treatment market forecast
• Binge-eating disorder treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading binge-eating disorder treatment market vendors that include Alvogen Iceland ehf, Bausch Health Co. Inc., Chronos Therapeutics Ltd., Currax Pharmaceuticals LLC, Eli Lilly and Co., Johnson and Johnson Services Inc., Lupin Ltd., Omeros Corp., Pyramid Healthcare Inc., Rosewood Centers for Eating disorders, Sumitomo Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., Timberline Knolls Residential Treatment Center, Tonix Pharmaceuticals Holding Corp., Tryp Therapeutics Inc., Viatris Inc., VIVUS LLC, and Walden Behavioral Care. Also, the binge-eating disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/binge-eating-disorder-treatment-market-analysis
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global binge-eating disorder treatment market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global binge-eating disorder treatment market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline - Market size and forecast 2022-2027
o Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 6.4 Online - Market size and forecast 2022-2027
o Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 Antidepressants - Market size and forecast 2022-2027
o Exhibit 48: Chart on Antidepressants - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Antidepressants - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Antidepressants - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Antidepressants - Year-over-year growth 2022-2027 (%)
o 7.4 Anticonvulsants - Market size and forecast 2022-2027
o Exhibit 52: Chart on Anticonvulsants - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Anticonvulsants - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Anticonvulsants - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Anticonvulsants - Year-over-year growth 2022-2027 (%)
o 7.5 Stimulants and others - Market size and forecast 2022-2027
o Exhibit 56: Chart on Stimulants and others - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Stimulants and others - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Stimulants and others - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Stimulants and others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Type
o Exhibit 60: Market opportunity by Type ($ million)
o Exhibit 61: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 India - Market size and forecast 2022-2027
o Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Alvogen Iceland ehf
o Exhibit 111: Alvogen Iceland ehf - Overview
o Exhibit 112: Alvogen Iceland ehf - Product / Service
o Exhibit 113: Alvogen Iceland ehf - Key offerings
o 12.4 Bausch Health Co. Inc.
o Exhibit 114: Bausch Health Co. Inc. - Overview
o Exhibit 115: Bausch Health Co. Inc. - Business segments
o Exhibit 116: Bausch Health Co. Inc. - Key news
o Exhibit 117: Bausch Health Co. Inc. - Key offerings
o Exhibit 118: Bausch Health Co. Inc. - Segment focus
o 12.5 Chronos Therapeutics Ltd.
o Exhibit 119: Chronos Therapeutics Ltd. - Overview
o Exhibit 120: Chronos Therapeutics Ltd. - Product / Service
o Exhibit 121: Chronos Therapeutics Ltd. - Key offerings
o 12.6 Currax Pharmaceuticals LLC
o Exhibit 122: Currax Pharmaceuticals LLC - Overview
o Exhibit 123: Currax Pharmaceuticals LLC - Product / Service
o Exhibit 124: Currax Pharmaceuticals LLC - Key offerings
o 12.7 Eli Lilly and Co.
o Exhibit 125: Eli Lilly and Co. - Overview
o Exhibit 126: Eli Lilly and Co. - Product / Service
o Exhibit 127: Eli Lilly and Co. - Key news
o Exhibit 128: Eli Lilly and Co. - Key offerings
o 12.8 Johnson and Johnson Services Inc.
o Exhibit 129: Johnson and Johnson Services Inc. - Overview
o Exhibit 130: Johnson and Johnson Services Inc. - Business segments
o Exhibit 131: Johnson and Johnson Services Inc. - Key news
o Exhibit 132: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 133: Johnson and Johnson Services Inc. - Segment focus
o 12.9 Lupin Ltd.
o Exhibit 134: Lupin Ltd. - Overview
o Exhibit 135: Lupin Ltd. - Product / Service
o Exhibit 136: Lupin Ltd. - Key news
o Exhibit 137: Lupin Ltd. - Key offerings
o 12.10 Omeros Corp.
o Exhibit 138: Omeros Corp. - Overview
o Exhibit 139: Omeros Corp. - Product / Service
o Exhibit 140: Omeros Corp. - Key offerings
o 12.11 Pyramid Healthcare Inc.
o Exhibit 141: Pyramid Healthcare Inc. - Overview
o Exhibit 142: Pyramid Healthcare Inc. - Product / Service
o Exhibit 143: Pyramid Healthcare Inc. - Key offerings
o 12.12 Sumitomo Pharma Co. Ltd.
o Exhibit 144: Sumitomo Pharma Co. Ltd. - Overview
o Exhibit 145: Sumitomo Pharma Co. Ltd. - Business segments
o Exhibit 146: Sumitomo Pharma Co. Ltd. - Key offerings
o Exhibit 147: Sumitomo Pharma Co. Ltd. - Segment focus
o 12.13 Takeda Pharmaceutical Co. Ltd.
o Exhibit 148: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 149: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 150: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 151: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.14 Tonix Pharmaceuticals Holding Corp.
o Exhibit 152: Tonix Pharmaceuticals Holding Corp. - Overview
o Exhibit 153: Tonix Pharmaceuticals Holding Corp. - Product / Service
o Exhibit 154: Tonix Pharmaceuticals Holding Corp. - Key offerings
o 12.15 Tryp Therapeutics Inc.
o Exhibit 155: Tryp Therapeutics Inc. - Overview
o Exhibit 156: Tryp Therapeutics Inc. - Product / Service
o Exhibit 157: Tryp Therapeutics Inc. - Key offerings
o 12.16 Viatris Inc.
o Exhibit 158: Viatris Inc. - Overview
o Exhibit 159: Viatris Inc. - Business segments
o Exhibit 160: Viatris Inc. - Key news
o Exhibit 161: Viatris Inc. - Key offerings
o Exhibit 162: Viatris Inc. - Segment focus
o 12.17 VIVUS LLC
o Exhibit 163: VIVUS LLC - Overview
o Exhibit 164: VIVUS LLC - Product / Service
o Exhibit 165: VIVUS LLC - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global binge-eating disorder treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Antidepressants - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Antidepressants - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Antidepressants - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Antidepressants - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Anticonvulsants - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Anticonvulsants - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Anticonvulsants - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Anticonvulsants - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Stimulants and others - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Stimulants and others - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Stimulants and others - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Stimulants and others - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Type ($ million)
Exhibits61: Data Table on Market opportunity by Type ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Alvogen Iceland ehf - Overview
Exhibits112: Alvogen Iceland ehf - Product / Service
Exhibits113: Alvogen Iceland ehf - Key offerings
Exhibits114: Bausch Health Co. Inc. - Overview
Exhibits115: Bausch Health Co. Inc. - Business segments
Exhibits116: Bausch Health Co. Inc. - Key news
Exhibits117: Bausch Health Co. Inc. - Key offerings
Exhibits118: Bausch Health Co. Inc. - Segment focus
Exhibits119: Chronos Therapeutics Ltd. - Overview
Exhibits120: Chronos Therapeutics Ltd. - Product / Service
Exhibits121: Chronos Therapeutics Ltd. - Key offerings
Exhibits122: Currax Pharmaceuticals LLC - Overview
Exhibits123: Currax Pharmaceuticals LLC - Product / Service
Exhibits124: Currax Pharmaceuticals LLC - Key offerings
Exhibits125: Eli Lilly and Co. - Overview
Exhibits126: Eli Lilly and Co. - Product / Service
Exhibits127: Eli Lilly and Co. - Key news
Exhibits128: Eli Lilly and Co. - Key offerings
Exhibits129: Johnson and Johnson Services Inc. - Overview
Exhibits130: Johnson and Johnson Services Inc. - Business segments
Exhibits131: Johnson and Johnson Services Inc. - Key news
Exhibits132: Johnson and Johnson Services Inc. - Key offerings
Exhibits133: Johnson and Johnson Services Inc. - Segment focus
Exhibits134: Lupin Ltd. - Overview
Exhibits135: Lupin Ltd. - Product / Service
Exhibits136: Lupin Ltd. - Key news
Exhibits137: Lupin Ltd. - Key offerings
Exhibits138: Omeros Corp. - Overview
Exhibits139: Omeros Corp. - Product / Service
Exhibits140: Omeros Corp. - Key offerings
Exhibits141: Pyramid Healthcare Inc. - Overview
Exhibits142: Pyramid Healthcare Inc. - Product / Service
Exhibits143: Pyramid Healthcare Inc. - Key offerings
Exhibits144: Sumitomo Pharma Co. Ltd. - Overview
Exhibits145: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits146: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits147: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits148: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits149: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits150: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits151: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits152: Tonix Pharmaceuticals Holding Corp. - Overview
Exhibits153: Tonix Pharmaceuticals Holding Corp. - Product / Service
Exhibits154: Tonix Pharmaceuticals Holding Corp. - Key offerings
Exhibits155: Tryp Therapeutics Inc. - Overview
Exhibits156: Tryp Therapeutics Inc. - Product / Service
Exhibits157: Tryp Therapeutics Inc. - Key offerings
Exhibits158: Viatris Inc. - Overview
Exhibits159: Viatris Inc. - Business segments
Exhibits160: Viatris Inc. - Key news
Exhibits161: Viatris Inc. - Key offerings
Exhibits162: Viatris Inc. - Segment focus
Exhibits163: VIVUS LLC - Overview
Exhibits164: VIVUS LLC - Product / Service
Exhibits165: VIVUS LLC - Key offerings
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations